By Jessica Thomas, LCSW Director of Patient Education, NETRF For many people living with neuroendocrine cancer, the journey begins with a singular focus: survival. A
By Anna C. Greene, PhD | NETRF Chief Scientific Officer In May, I attended the 2026 Small Cell Lung Cancer Consortium hosted by the National
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, NETRF Chief Scientific Officer You asked. We’re answering. Through the
By Anna C. Greene, PhD, NETRF Chief Scientific Officer At the Neuroendocrine Tumor Research Foundation (NETRF), we fund research that can change how neuroendocrine cancers
By Carrie Camino, Member, NETRF Board of Directors Last month I had the extraordinary opportunity to attend the American Association of Cancer Research (AACR) as
By Anna C. Greene, PhD, NETRF Chief Scientific Officer The American Association for Cancer Research Annual Meeting, known as AACR, is one of the largest
Research-informed answers to your most important questions about neuroendocrine cancer. By Anna C. Greene, PhD, Chief Scientific Officer, Neuroendocrine Tumor Research Foundation (NETRF) You asked.
Leo Giancola lost his mom Ivette Giancola to neuroendocrine cancer when he was still in kindergarten. While his memories of her at that age are
When we launched Breakthroughs Today, Cures Tomorrow, we made a promise: to accelerate the science that leads to better treatments and, ultimately, cures for neuroendocrine
More than 1,100 patients and caregivers from across the United States and internationally participated in NETRF’s 2026 Annual Patient and Caregiver Survey, sharing their experiences,